![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
University of Chicago |
Information provided by: | University of Chicago |
ClinicalTrials.gov Identifier: | NCT00152620 |
The aim of this therapeutic trial is to compare the response of subjects with active IBD to daily intravenous dexamethasone versus the response to daily intravenous methylprednisolone.
Condition | Intervention |
Inflammatory Bowel Disease (IBD) |
Drug: Dexamethasone Drug: Methylprednisolone |
Genetics Home Reference related topics: | Crohn disease |
ChemIDplus related topics: | Dexamethasone Dexamethasone acetate Dexamethasone Sodium Phosphate Doxiproct plus Methylprednisolone |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment |
Official Title: | Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease |
Ages Eligible for Study: | 6 Years to 19 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Illinois | |||||
University of Chicago Comer Children's Hospital | |||||
Chicago, Illinois, United States, 60637 |
University of Chicago |
Principal Investigator: | Barbara S Kirschner, MD | University of Chicago |
Study ID Numbers: | 13171B |
First Received: | September 7, 2005 |
Last Updated: | April 30, 2007 |
ClinicalTrials.gov Identifier: | NCT00152620 |
Health Authority: | United States: Institutional Review Board |
|
|
|
|
|
![]() |